tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Chang, 77 are a BUY (64.71%), 42 are a HOLD (35.29%).
Analyst Jonathan Chang, carries an average stock price target met ratio of 55.23% that have a potential upside of 37.2% achieved within 252 days. Previously, Jonathan Chang worked at LEERINK.
Jonathan Chang’s has documented 204 price targets and ratings displayed on 19 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on REPL, Replimune Group at 22-Jul-2025.
Analyst best performing recommendations are on IMGN (IMMUNOGEN).
The best stock recommendation documented was for REPL (REPLIMUNE GROUP) at 7/22/2025. The price target of $3 was fulfilled within 1 day with a profit of $0.19 (6.76%) receiving and performance score of 67.62.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$1
$-0.01 (-0.99%)
$4
2 years 21 days ago
(10-Aug-2023)
3/4 (75%)
$0.18 (21.95%)
245
Buy
$5
$3.99 (395.05%)
2 years 7 months 28 days ago
(03-Jan-2023)
0/2 (0%)
$3.33 (199.40%)
Buy
$9
$8.22 (1053.85%)
$9
2 years 9 months 22 days ago
(09-Nov-2022)
2/3 (66.67%)
$1.29 (98.13%)
340
Hold
$3
$1.99 (197.03%)
3 years 3 months 22 days ago
(09-May-2022)
1/5 (20%)
$1.46 (94.81%)
377
Buy
$6
$5.22 (669.23%)
$16
6 years 3 months 24 days ago
(07-May-2019)
1/3 (33.33%)
$6.36 (92.59%)
388
Which stock is Jonathan Chang is most bullish on?
Which stock is Jonathan Chang is most reserved on?
What Year was the first public recommendation made by Jonathan Chang?
